Mounjaro contains tirzepatide, a medication that may support weight loss by reducing appetite, increasing feelings of fullness, and slowing the movement of food through the stomach. These effects may make it easier to manage portion sizes and maintain a reduced-calorie eating plan.

Whether Mounjaro is appropriate depends on several factors, including your current weight, body mass index, weight-related health concerns, medical history, medications, and previous weight-loss efforts. Results vary, and the medication works best when combined with balanced nutrition, regular physical activity, adequate sleep, and consistent medical follow-up.

At Cape Fear Physical Medicine and Rehab, we evaluate each patient before recommending a medical weight-loss medication. We can determine whether Mounjaro may be suitable for your goals, explain potential side effects, monitor your progress, and create a personalized plan designed to support safe, steady, and sustainable weight loss.

Mounjaro may begin affecting appetite and blood sugar soon after treatment starts, but visible weight loss usually develops gradually. Tirzepatide reaches a steady concentration after about four weeks of weekly dosing. Because the dose is increased slowly, some patients notice changes over several weeks rather than immediately.

Results vary depending on the starting dose, dose tolerance, nutrition, physical activity, sleep, medical conditions, and treatment adherence. Clinical trials evaluating tirzepatide for obesity measured substantial weight reduction over months, including a 72-week study. Early changes do not predict the final result, and rapid loss is not always healthier or sustainable.

At Cape Fear Physical Medicine and Rehab, our team monitors response to medication and adjusts recommendations according to progress and side effects. Regular follow-up allows her to review appetite changes, weight trends, and health while helping patients build habits that support steady, medically supervised weight management over time.

The amount of weight lost with tirzepatide varies from person to person. In a 72-week trial involving adults with obesity or overweight without diabetes, average weight reductions were approximately 15.0% with 5 mg, 19.5% with 10 mg, and 20.9% with 15 mg. Individual results may be higher or lower.

Weight loss depends on factors such as starting weight, dose, treatment duration, medication tolerance, eating patterns, activity level, sleep, and health conditions. People with type 2 diabetes may experience different results from participants in obesity trials. These percentages are study averages, not guarantees, and treatment should focus on health improvements rather than a specific number.

At Cape Fear Physical Medicine and Rehab, our team establishes weight goals before treatment. We track changes in weight, symptoms, and health, then adjust the plan when appropriate. Ongoing medical guidance helps patients evaluate progress safely and develop habits that support long-term results.

Weight regain can occur after stopping Mounjaro or another tirzepatide medication because its effects on appetite and calorie intake lessen when treatment ends. In the SURMOUNT-4 trial, participants lost an average of 20.9% during 36 weeks of tirzepatide. Those switched to placebo regained about 14% over the following 52 weeks.

Not everyone regains the same amount, and stopping does not automatically mean returning to the starting weight. Long-term results may be influenced by nutrition, physical activity, sleep, stress, medical conditions, and the plan used when medication is discontinued. Tirzepatide should not be stopped or changed without discussing it with the prescribing clinician.

At Cape Fear Physical Medicine and Rehab, Dr. Meisha K. Abbasinejad, MD, can help patients prepare for medication changes and protect progress. Follow-up may include reviewing appetite, weight trends, lifestyle habits, and alternatives. A maintenance plan can help reduce regain and support continued weight management after treatment changes.

Dr. Meisha K. Abbasinejad, MD, is a trusted choice for Mounjaro weight loss care because she evaluates each patient’s health history, current medications, previous weight-loss efforts, and personal goals before recommending treatment. Her medical guidance helps determine whether Mounjaro may be appropriate while ensuring that patients understand how the medication works, what results may be realistic, and which potential side effects should be monitored.

At Cape Fear Physical Medicine and Rehab, Dr. Abbasinejad provides personalized follow-up throughout the weight loss journey. She monitors progress, evaluates medication tolerance, and adjusts recommendations when medically appropriate. Patients also receive guidance on nutrition, physical activity, and sustainable habits to support steady weight loss and long-term weight management. At Cape Fear Physical Medicine and Rehab, we are committed to helping you achieve your weight loss goals with safe and effective treatments. Our professional team provides personalized support and guidance while using Mounjaro to ensure optimal results. Contact us today or schedule an appointment to learn more about how Mounjaro can help you on your weight loss journey. We are conveniently located at 1540 Purdue Dr, Ste. 200, Fayetteville, NC 28303. We serve patients from Fayetteville NC, Woodfield NC, Hope Mills NC, Fort Bragg NC, Eastover NC, and surrounding areas.